Data from EMA (European Medicines Agency) - Curated by Marshall Pearce - Last updated 12 January 2018

Indication(s)

Spinraza is indicated for the treatment of 5q Spinal Muscular Atrophy.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

Type 2 Diabetes

Type 2 Diabetes

View the latest epidemiology data, patient perspectives, ADA and EASD recommendations, treatment options and more.

Obesity

Obesity

Learn about the complex factors influencing development of obesity.

+ 4 more

Load more

Related Content

More information

Category Value
Agency product number EMEA/H/C/004312
Orphan designation Yes
Date First Approved 30-05-2017
Type Medicinal product subject to restricted medical prescription
Marketing authorisation holder Biogen Idec Ltd